Ondansetron is an antiemetic drug that works in cats by blocking serotonin receptors involved in triggering vomiting, and it has become a common option veterinarians reach for when a cat is nauseated or actively vomiting. Originally developed for humans undergoing chemotherapy, it crossed into veterinary medicine because cats share the same serotonin-driven vomiting pathways. The drug is effective, but its usefulness in cats depends heavily on how it is given, what is causing the vomiting, and whether the cat has any underlying organ disease that changes how the body processes it.
How Ondansetron Stops Vomiting in Cats
Cats vomit through a surprisingly complex network of signals. The brain’s vomiting center receives input from several places: the chemoreceptor trigger zone (a region that detects toxins in the blood), the gut itself (via the vagus nerve), and even the inner ear. Serotonin, specifically the 5-HT3 receptor, plays a major role in relaying these signals from the gut to the brain. When something irritates the stomach or intestines, cells in the gut lining release serotonin, which activates nearby nerve endings and sends “time to vomit” messages up the vagus nerve to the brainstem.
Ondansetron blocks 5-HT3 receptors, intercepting those signals before they reach the vomiting center. This makes it particularly effective when nausea originates from the gut, as happens with gastritis, inflammatory bowel disease, or chemotherapy-induced irritation. It also blocks 5-HT3 receptors in the chemoreceptor trigger zone itself. The ACVIM consensus statement on feline pancreatitis describes ondansetron as a serotonin receptor antagonist that can serve as either a primary or an add-on antiemetic in cats.1PubMed Central. ACVIM consensus statement on pancreatitis in cats
Why the Route of Administration Matters So Much
One of the most practically important things about ondansetron in cats is that how you give it dramatically changes how much of the drug actually reaches the bloodstream. A pharmacokinetic study in healthy cats found that oral ondansetron had a bioavailability of only about 32%, meaning roughly two-thirds of the dose never made it into circulation. Subcutaneous injection, by contrast, achieved about 75% bioavailability.2PubMed Central. Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats
The elimination half-life also varies by route. Intravenous ondansetron cleared the body with a half-life of roughly 1.8 hours, oral was even shorter at about 1.2 hours, and subcutaneous lasted longest at around 3.2 hours. That subcutaneous half-life was significantly longer than either of the other routes.3PubMed Central. Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy cats In practical terms, a subcutaneous injection delivers more drug into the system and keeps it there longer, which is why many veterinarians prefer this route for cats that are already vomiting (and therefore unlikely to keep a pill down anyway).
Intravenous dosing gives the fastest onset, making it the go-to choice in emergency settings or during anesthesia when the drug needs to work immediately. Oral dosing is the most convenient for owners administering the drug at home, but that low bioavailability means more frequent dosing may be necessary, and a vomiting cat may not absorb the pill at all.
Transdermal Ondansetron Does Not Work
Because pilling cats is famously difficult, transdermal medications applied to the inner ear flap have gained popularity for other drugs. On paper, ondansetron seemed like it might work this way: it has properties that pharmacologists look for in a transdermal candidate. In practice, it does not. A study testing 4 mg of transdermal ondansetron in cats found no clinically relevant drug levels in the blood after either single or multiple doses.4PubMed Central. Assessment of absorption of transdermal ondansetron in normal research cats
This is worth knowing because compounding pharmacies do offer transdermal ondansetron formulations for cats, and some owners may assume that any formulation sold for cats has been shown to work. The research says otherwise: despite the drug’s theoretical suitability for skin absorption, transdermal application at this dose simply does not deliver enough ondansetron into the bloodstream to have an antiemetic effect. If your veterinarian prescribes ondansetron and pilling is not an option, subcutaneous injection is the route with the best evidence behind it.
How Ondansetron Compares to Maropitant
Maropitant (sold under the brand name Cerenia) is the other major antiemetic used in cats. It works through a completely different mechanism, blocking NK1 (neurokinin-1) receptors instead of serotonin receptors. Because NK1 receptors sit in the vomiting center itself rather than primarily on peripheral nerves, maropitant is sometimes considered a broader-spectrum antiemetic. The natural question is whether one drug outperforms the other.
The evidence so far suggests they are roughly equivalent for most clinical situations in cats. A study comparing maropitant, ondansetron, and metoclopramide for preventing vomiting caused by the sedative dexmedetomidine found no significant differences in either the frequency or the severity of vomiting among the three drug groups.5PubMed Central. The Effect of Maropitant, Ondansetron and Metoclopramide on Dexmedetomidine‐Induced Vomiting in Cats A separate clinical study in cats with acute vomiting from various causes similarly found that a single dose of either ondansetron or maropitant controlled vomiting and nausea within the first 24 hours with comparable effectiveness.6Journal of the Hellenic Veterinary Medical Society. Comparing the Antiemetic Effects of Maropitant and Ondansetron in Cats with Acute Vomiting in Clinical Practice
That said, the overall evidence base for ondansetron in cats is thinner than for maropitant. A systematic review and meta-analysis of antiemetic strategies in cats noted that ondansetron evidence was limited to just two sources and hinted at a possible timing-dependent benefit, while maropitant had a broader pool of data supporting its use.7PubMed Central. Receptor-Targeted Antiemetic Strategies in Cats: A Systematic Review and Intervention-Specific Meta-Analysis The “timing-dependent benefit” observation is important and worth unpacking: ondansetron may work better when given at certain points relative to the nausea trigger rather than after vomiting has already started.
Timing and Pre-Anesthetic Use
One of the more specific clinical uses of ondansetron in cats is preventing vomiting during sedation. Dexmedetomidine, a sedative commonly used before anesthesia, frequently causes cats to vomit. This is more than a nuisance: vomiting under sedation carries a risk of aspiration, where stomach contents enter the airways.
A controlled trial found that ondansetron at a dose of 0.22 mg/kg significantly reduced both the number of cats that vomited and the severity of nausea when it was given together with dexmedetomidine. The study specifically noted that ondansetron “ameliorates and reduced the severity of dexmedetomidine-induced nausea and vomiting only when it was administered in association with this drug,” meaning the timing of the dose relative to the sedative mattered.8Veterinary Anaesthesia and Analgesia. A randomized, blinded, controlled trial of the antiemetic effect of ondansetron on dexmedetomidine-induced emesis in cats Giving ondansetron well before or well after the sedative was less effective than giving it alongside the sedative. This aligns with what the systematic review flagged as a timing-dependent benefit: ondansetron’s relatively short half-life means it needs to be circulating when the emetic stimulus hits.
This has practical implications beyond the operating room. If your cat is receiving any medication known to cause nausea, the timing of the ondansetron dose relative to that medication matters. Giving it an hour too early or too late could mean the drug has already been cleared from the body by the time it is needed.
Kidney Disease, Liver Disease, and Dose Adjustments
Many cats that need antiemetics are not otherwise healthy. Chronic kidney disease is one of the most common conditions in aging cats, and nausea is one of its hallmark symptoms. Liver disease also frequently triggers vomiting. Both of these conditions change how a cat’s body handles ondansetron, which has practical consequences for dosing.
A pharmacokinetic study compared subcutaneous ondansetron in three groups: healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease. Cats with kidney disease had higher drug exposure (measured as area under the curve) than healthy geriatric cats, and cats with liver disease had even higher exposure still. Drug clearance was slower in both disease groups.9PubMed Central. Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease In plain terms, sick cats keep ondansetron in their system longer and at higher concentrations than healthy cats do.
This is a double-edged situation. On one hand, it means the drug may last longer in the cats that need it most. On the other hand, higher and more prolonged drug levels raise the potential for side effects, even with a drug that has a generally good safety profile. Veterinarians may need to extend the interval between doses or reduce the dose itself in cats with significant kidney or liver impairment. This is not a situation where owners should adjust doses on their own; the pharmacokinetic changes are real but unpredictable enough that veterinary guidance is needed for each cat.
Ondansetron in Feline Pancreatitis
Pancreatitis is a painful and often life-threatening condition in cats that almost universally causes nausea and vomiting. The ACVIM consensus statement on feline pancreatitis lists ondansetron as one of the antiemetics that can be used, either as the primary antiemetic or in combination with other drugs.10PubMed Central. ACVIM consensus statement on pancreatitis in cats Controlling vomiting in pancreatitis is not just about comfort. Persistent vomiting leads to dehydration, electrolyte imbalances, weight loss, and in cats specifically, a dangerous condition called hepatic lipidosis, where the liver becomes overwhelmed by mobilized fat stores during periods of not eating.
Because pancreatitis frequently occurs alongside kidney disease and liver involvement in cats (a cluster sometimes called “triaditis” when the intestines are also inflamed), the altered pharmacokinetics described above are directly relevant. A cat with pancreatitis and concurrent kidney disease may process ondansetron differently than a cat with pancreatitis alone. The treatment protocol for these overlapping conditions requires careful veterinary management, often involving injectable antiemetics, IV fluids, pain management, and nutritional support delivered simultaneously.
Side Effects and Safety
Ondansetron is considered one of the safer antiemetics available for cats. In the pharmacokinetic studies conducted in healthy cats, no significant adverse effects were reported at standard doses across all three routes of administration (oral, subcutaneous, and intravenous). The drug does not cause the sedation or behavioral changes sometimes seen with other antiemetics, and it does not have the dopamine-blocking effects of metoclopramide, which can occasionally cause neurological side effects in cats.
That said, the research specifically focused on ondansetron safety in cats is limited compared to what exists in human medicine. Most of the feline studies were designed to measure efficacy or pharmacokinetics, with safety noted as a secondary observation. The absence of reported adverse effects in small studies is reassuring but is not the same as a large-scale safety trial demonstrating that side effects are rare. In human medicine, ondansetron’s known side effects include headache, constipation, and in rare cases, heart rhythm changes. Whether these occur in cats at similar rates is not well-characterized, partly because headache is impossible to assess in a cat and constipation may go unnoticed in a hospitalized patient.
The most meaningful safety consideration is the drug interaction landscape. Ondansetron is metabolized by liver enzymes, so any other medication that competes for those same enzymes could raise ondansetron levels or be affected by it. This is especially relevant in cats already receiving multiple medications for complex illnesses.
Why Metoclopramide Is Falling Out of Favor
Metoclopramide is an older antiemetic that works partly by blocking dopamine receptors and partly through effects on gut motility. It was once widely used in cats but has been increasingly overshadowed by ondansetron and maropitant. In the dexmedetomidine vomiting study, metoclopramide performed comparably to the other two drugs.11PubMed Central. The Effect of Maropitant, Ondansetron and Metoclopramide on Dexmedetomidine‐Induced Vomiting in Cats But the systematic review found that metoclopramide evidence in cats was limited to just one directly comparable study and was insufficient for drawing pooled conclusions.12PubMed Central. Receptor-Targeted Antiemetic Strategies in Cats: A Systematic Review and Intervention-Specific Meta-Analysis
Beyond the limited evidence, metoclopramide’s dopamine-blocking activity is a concern in cats. Dopamine antagonism can cause restlessness, involuntary movements, and other neurological effects. Ondansetron avoids this entirely because it works on serotonin receptors rather than dopamine receptors. For cats that need ongoing antiemetic therapy rather than a single dose, the neurological safety profile of ondansetron makes it a more appealing long-term option.
Reading Nausea in a Cat
One of the underappreciated challenges with antiemetic therapy in cats is knowing whether the drug is actually working against nausea, not just vomiting. Cats can be profoundly nauseated without vomiting. Signs of nausea in cats include lip-licking, excessive swallowing, drooling, turning away from food, and a hunched or tense posture. Some cats become very still and withdrawn; others vocalize. These signs are easy to miss or attribute to pain, stress, or simply “being a cat.”
In the controlled trial of ondansetron for dexmedetomidine-induced emesis, researchers used a numerical rating scale to quantify nausea signs, not just vomiting episodes. Ondansetron reduced the severity of nausea, not only the frequency of vomiting.13Veterinary Anaesthesia and Analgesia. A randomized, blinded, controlled trial of the antiemetic effect of ondansetron on dexmedetomidine-induced emesis in cats This distinction matters at home, too. If your cat has stopped vomiting on ondansetron but is still refusing food, drooling, or acting withdrawn, the nausea may not be fully controlled. Mentioning these subtle signs to your veterinarian can help them decide whether to adjust the dose, change the route, or add a second antiemetic targeting a different receptor pathway.
Appetite is often the most reliable at-home gauge. The clinical study comparing ondansetron and maropitant in cats with acute vomiting tracked activity and appetite scores alongside vomiting, and both drugs improved appetite by the end of the observation period.14Journal of the Hellenic Veterinary Medical Society. Comparing the Antiemetic Effects of Maropitant and Ondansetron in Cats with Acute Vomiting in Clinical Practice A cat that resumes eating is generally a cat whose nausea is under reasonable control. A cat that stops vomiting but still will not eat may need a different approach.